0001140361-13-043233.txt : 20131115 0001140361-13-043233.hdr.sgml : 20131115 20131115183618 ACCESSION NUMBER: 0001140361-13-043233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131113 FILED AS OF DATE: 20131115 DATE AS OF CHANGE: 20131115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROBERTS CHRISTOPHER G CENTRAL INDEX KEY: 0001186112 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 131225040 MAIL ADDRESS: STREET 1: 97 WATERLOO ROAD CITY: NORTH RYDE STATE: C3 ZIP: 2113 4 1 doc1.xml FORM 4 X0306 4 2013-11-13 0 0000943819 RESMED INC RMD 0001186112 ROBERTS CHRISTOPHER G RESMED INC. 9001 SPECTRUM CENTER BLVD. SAN DIEGO CA 92123 1 0 0 0 ResMed Common Stock 2013-11-13 4 A 0 2488 0 A 92488 D ResMed Common Stock 242400 I Cabbit Pty Ltd ResMed Common Stock 136000 I AceMed Pty Ltd ResMed Common Stock 23200 I Spouse ResMed Stock Options 51.25 2013-11-13 4 A 0 10356 0 A 2016-11-11 2020-11-13 ResMed Common Stock 10356 10356 D Shares awarded are Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2014 or the annual shareholder's meeting in the year following the grant date. Only 50% will distribute upon vesting; the remaining 50% require a holding period until the earlier of the third annual shareholder's meeting following the grant date or 6 months after termination of service. Options vest in full (i) on the first Nov. 11 following grant date or (ii) the first annual shareholder's meeting following grant date. Options have a required holding period until the earlier of (i) Nov. 11 of the third year following grant date or (ii) six months following termination of directorship. Christopher G. Roberts 2013-11-15